A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer

Clinical trial NCT00246597 · TERMINATED

Trial details

NCT number: NCT00246597
Sponsor: Ortho Biotech Products, L.P.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Anemia Breast Neoplasms Hemoglobins Quality of Life Chemotherapy, Adjuvant

Start date: 2002-12-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.